Journal article
Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade
Abstract
BACKGROUND: Sugammadex is the first selective relaxant binding agent that has been studied for reversal of neuromuscular blockade induced by rocuronium and other steroidal non-depolarizing neuromuscular blocking agents (NMBAs).
OBJECTIVES: To assess the efficacy and safety of sugammadex in reversing neuromuscular blockade induced by steroidal non-depolarizing NMBAs and in preventing postoperative residual neuromuscular blockade.
Authors
Abrishami A; Ho J; Wong J; Yin L; Chung F
Journal
Cochrane Database of Systematic Reviews, , No. 4,
Publisher
Wiley
DOI
10.1002/14651858.cd007362.pub2
ISSN
1361-6137